Active Ingredients
Influenzinum HPUS
8X, 30X, 6C, 9C, 12C, 15C, 30C, 200CK
Influenzinum
FDA Label NDC 0220-2651
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Laboratoires Boiron for the product Influenzinum (NDC 0220-2651). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, use, stop use and ask a doctor if, if pregnant or breast-feeding,, directions, other information, inactive ingredients, questions, comments?, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Use
After-effects of flu or flu-like symptoms*
Stop Use And Ask A Doctor If
symptoms persist for more than 3 days or worsen.
If Pregnant Or Breast-Feeding,
ask a health professional before use.
Directions
5 pellets 3 times a day until symptoms are relieved.
Other Information
Do not use if pellet dispenser seal is broken.
contains approx. 80 pellets
Inactive Ingredients
lactose, sucrose
Questions, Comments?
1-800-BOIRON-1
Newtown Square, PA 19073-3267
[email protected]
*
These "Uses" have not been evaluated by the FDA.
Principle Display Panel - Influenzinum Hpus 8X
Image (8x)
Principle Display Panel - Influenzinum Hpus 30X
Image (30x)
Principle Display Panel - Influenzinum Hpus 6C
Image (6c)
Principle Display Panel - Influenzinum Hpus 9C
Image (9c)
Principle Display Panel - Influenzinum Hpus 12C
Image (12c)
Principle Display Panel - Influenzinum Hpus 15C
Image (15c)
Principle Display Panel - Influenzinum Hpus 30C
Image (30c)
Principle Display Panel - Influenzinum Hpus 200Ck
Image (200ck)
Principle Display Panel - Influenzinum Hpus 9C - Single Dose
Image (9c Sd)
* Please review the disclaimer below.
